NOVEMBER 6, 2021 from10:00 AM - 6:30 PM EST



OUR SPEAKERS

We are excited to share with you all, a sneak peek of the amazing lineup of seasoned experts on Nuclear Medicine and its many facets. Special thanks to the scientific committee and its chairman, Dr. Andrew Ross, for putting together this amazing program. 


Are you joining us on November 6th?

 

Session 1 - Response to Therapy - Immunotherapy

  



 

Dr. Stephanie Snow has been a staff Medical Oncologist at the QEII hospital in Halifax, Nova Scotia since 2010 andis currently an Associate Professor at in the Faculty of Medicine at Dalhousie. 
  Dr. Annick D. Van Den Abbeele is the Chief of the Department of Imaging, Director of Nuclear Medicine/PET, and Founding Director of the Center for Biological Imaging in Oncology (CBIO) at Dana-Farber Cancer Institute. She also serves as Co-Director of the Tumor Imaging Metrics Core (TIMC) at Dana-Farber/Harvard Cancer Center and is an Associate Professor of Radiology at Harvard Medical School. 

Session 2A - Nuclear Medicine Response & Eric Lepp award

      

  Dr. Steven Burrell is head of Nuclear Medicine at the QEII Health Sciences Centre and Professor of Radiology at Dalhousie University. He has been research director for Dalhousie/QEII Radiology and residency program director for Dalhousie Nuclear Medicine. His clinical and research interests include imaging of cancer, cardiac disease, and osteoporosis. 
  Dr. Peter George Maliha is a PGY5 nuclear medicine resident from McGill University, Montreal, Quebec. Endeavoring an academic career, he has supplemented his clinical training with multiple research projects on, amongst other subjects, FDG PET appropriate use, PSMA, vasculitis and digital PET. 
  Dr. Jeffrey Wagner, MD, FRCPC Associate Staff, Moncton Hospital Graduated Medicine from Dalhousie University (2014) Completed Radiology residency at University of Alberta (2019)

LUNCH AND VIRTUAL SPONSOR'S EXHIBIT TIME

Session 2B - Nuclear Medicine Response & Amyloidosis

    Dr. Éric Turcotte - Many in medical community regard Dr. Turcotte as a leading authority and much-sought-after speaker on PET scan and PET tracer development. Dr Turcotte graduated from University of Sherbrooke School of Medicine and completed his specialist training in Nuclear medicine. He continued with post-doctoral fellowship in Nuclear medicine at University of Washington, Seattle (WA).   
     Dr. Frédéric Arsenault  MD, MSc, FRCPC, Specialist in nuclear medicine at CHU de Québec, Laval University
    Dr. Matthieu Pelletier Galarneau, MD Msc FRCPC, is the head of the Nuclear Medicine Division at the Montreal Heart Institute. He is also a Radiology Instructor at Harvard Medical School. 
    Dr. Hanane Benbarkat Cardiologist at Maisonneuve Rosemont Hospital, head of the heart failure and cardio-oncology clinic. Studied medicine at McGill University and completed additional training in cardiac ultrasound and cardio-oncology at Queens University.
   

Dr Mathew Bligh M.D, M.A.Sc, Currently faculty in the Dept. of Diagnostic Radiology at Dalhousie University, staff physician in the Dept. of Diagnostic Imaging at Saint John Regional Hospital in Saint John NB. Completed combined residency in radiology and nuclear medicine and radiology at Dalhousie University in Halifax NS

 

Session 3 - Abstracts Session

    Dr. Jessica Dobson is a Radiology & Nuclear Medicine resident at Dalhousie University. After completing her Bachelor of Science in chemistry and political science at the University of New Brunswick, she attended Memorial University of Newfoundland where she received her medical degree and certificate in medical teaching in 2020. She is currently the Chair of the Canadian Association of Radiologist (CAR) Resident & Fellows Section, through which role she worked to create a national Medical Student Network to promote radiology among Canadian medical students.  
    Dr. Kamel Hasan Olfat, is a Nuclear Medcine and Molecular Imaging Specialist at McMaster University 
    Dr. Macdonald completed a PhD at Dalhousie University. His graduate research involved the development of radiopharmaceuticals and neuroimaging approaches towards the definitive diagnosis of Alzheimer’s disease. Dr. Macdonald subsequently completed his MD and is currently in the combined Nuclear Medicine/Diagnostic Radiology Residency program at Dalhousie University. 

Session 4 - The future in Nuclear Medicine 

    Professor Michael Hofman is a nuclear medicine physician at the Peter MacCallum Cancer Centre in Melbourne, Australia's only public hospital dedicated to cancer treatment, research and education. He has a co-appointment at the University of Melbourne and previously completed a fellowship at Guy's & St Thomas' hospital in London. Professor Hofman is Director of the Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) at Peter Mac. 
    Dr. Rodd Hicks is a Professorial Fellow of the University of Melbourne and until recently was the Director of the Centre for Molecular Imaging and Therapeutic Nuclear Medicine at the Peter MacCallum Cancer Centre in Melbourne, Australia. 


SCIENTIFIC COMMITTEE / COMITÉ SCIENTIFIQUE

Jean-Luc Urbain, Chair

Jonathan Abele

Peter Maliha

Andrew Ross

Salem Yuoness




Powered by Wild Apricot Membership Software